Research output

Cost-effectiveness of gastro-resistant risedronate tablets for the treatment of postmenopausal women with osteoporosis in France

Research output: Contribution to journalArticleAcademicpeer-review

Associated researcher

Associated organisations

    Research areas

  • Cost-effectiveness, Economic evaluation, Osteoporosis, Risedronate, Treatment, QUALITY-OF-LIFE, ECONOMIC-EVALUATION, INTERVENTION THRESHOLDS, ORAL BISPHOSPHONATES, EXCESS MORTALITY, HIP FRACTURE, PERSISTENCE, ADHERENCE, HOSPITALIZATION, BURDEN
View graph of relations

Details

Original languageEnglish
Pages (from-to)649-658
Number of pages10
JournalOsteoporosis International
Volume30
Issue number3
DOIs
Publication statusPublished - Mar 2019